1CM's revenue for the
three
months ended in Feb. 2026 was $13.07 Mil.
Its revenue for the trailing twelve months (TTM) ended in Feb. 2026 was $54.21 Mil.
1CM's Revenue per Share for the
three
months ended in Feb. 2026 was $0.11.
Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was $0.46.
Warning Sign:
1CM Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of 1CM was 12.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 310.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 318.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, 1CM's highest 3-Year average Revenue per Share Growth Rate was 577.50% per year. The lowest was 26.00% per year. And the median was 310.60% per year.
1CM (OTCPK:MILFF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
1CM Revenue Related Terms
1CM Revenue Historical Data
* Premium members only.
The historical data trend for 1CM's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1CM Revenue vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1CM's Revenue distribution charts can be found below:
* The bar in red indicates where 1CM's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $54.21 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1CM (MILFF) has a Revenue of $54.21 Mil as of Feb. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on 1CM and its competitors.
Is 1CM's Revenue too high?
1CM's current Revenue is $54.21 Mil. Overall, 1CM has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 1CM's Revenue compare to ZTS and UTHR?
1CM's Revenue of $54.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on 1CM and its competitors. 1CM's current Revenue is $54.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1CM stock overvalued right now?
Based on GuruFocus' analysis, 1CM (MILFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.34, compared to a current price of $0.08 — trading 77% below its estimated fair value. The current Revenue is $54.21 Mil. 1CM's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For 1CM (MILFF), the current Revenue is $54.21 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 1CM (MILFF) Overvalued in 2026?
Based on GuruFocus' analysis, 1CM stock appears to be undervalued.
The current stock price of $0.08 is trading 77% below its estimated GF Value™ of $0.34.
GuruFocus considers 1CM to be Significantly Undervalued.
Key valuation signals for MILFF:
Revenue: $54.21 Mil
GF Value™: $0.34 vs. price of $0.08 (77% below fair value)
No single metric tells the full story. See the MILFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
1CM Inc is a multi-jurisdictional cannabis company focused on its retail customers and technology to democratize cannabis markets. The Company focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions. It has a single operating segment, being Cannabis.
50GF Score
Get the complete analysis for MILFF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MILFF has been successfully added to your 
